Home › NCT05790655
Ovarian PRP for Diminished Ovarian Reserve
Ovarian Platelet-Rich Plasma Injections for Diminished Ovarian Reserve Patients: A Double-Blinded Placebo-Control Trial
Who can join
Ages 35 to 42 · Women · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Clinical diagnosis of diminished ovarian reserve * Clinical diagnosis of poor ovarian response * Women age 35-42 Exclusion Criteria: * Clinical diagnosis of premature ovarian failure * Clinical diagnosis of menopause. * Under 35 years of age * Over 42 years of age
About the study
This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.
What is being tested
- oPRP (other)
- Placebo- Serum (other)
Sponsor: Generation Next Fertility · Participants: 230 · Started: Oct 7, 2023
Contact the study team
- Alicia Broussard, PhD · Phone: 3174456958
- Jesse Hade, MD · Phone: 2126410906
Official record on ClinicalTrials.gov — NCT05790655
Locations in the U.S.
| New York | Generation Next Fertility, New York |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.